期刊文献+

苓甘五味姜辛汤联合三子养亲汤治疗哮喘-慢阻肺重叠综合征的临床观察 被引量:10

Clinical observation of Linggan Wuwei Jiangxin Decoction combined with Sanzi Yangqin Decoction in the treatment of asthma-chronic obstructive pulmonary disease overlap syndrome
下载PDF
导出
摘要 目的:探讨苓甘五味姜辛汤联合三子养亲汤治疗哮喘-慢阻肺重叠综合征(ACOS)的临床疗效。方法:2016年1月-2018年12月收治ACOS患者80例,随机分为两组。对照组采取常规治疗,治疗组在常规治疗基础上给予苓甘五味姜辛汤联合三子养亲汤治疗。比较两组治疗效果。结果:治疗组临床总有效率、1 s用力呼气量(FEV1)、1 s用力呼气容积占肺活量百分比(FEV1/FVC%)水平均高于对照组,哮喘症状评分(ACT)、慢阻肺症状评分(CAT)均低于对照组,差异有统计学意义(P<0.05)。结论:苓甘五味姜辛汤联合三子养亲汤治疗ACOS效果显著。 Objective:To explore the clinical effect of Linggan Wuwei Jiangxin Decoction combined with Sanzi Yangqin Decoction in the treatment of asthma-chronic obstructive pulmonary disease overlap syndrome(ACOS).Methods:From January 2016 to December 2018,80 patients with ACOS were selected and randomly divided into two groups.The control group was treated with routine treatment.The treatment group was treated with Linggan Wuwei Jiangxin Decoction combined with Sanzi Yangqin Decoction on the basis of conventional treatment.We compared the efficacy of the two groups.Results:The total clinical effective rate of the treatment group was higher than that of the control group,the difference was statistically significant(P<0.05).In the treatment group,the level of one second forced expiratory volume(FEV1)and one second forced expiratory volume as a percentage of vital capacity(FEV1/FVC%)in the treatment group were higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:The clinical effect of Linggan Wuwei Jiangxin Decoction combined with Sanzi Yangqin Decoction in the treatment of ACOS is better.
作者 邓秀娟 谭宇军 Deng Xiujuan;Tan Yujun(Affiliated Hospital of Chinese Medicine Research Institute of Hunan Province,Hunan Changsha 410006)
出处 《中国社区医师》 2020年第16期88-89,共2页 Chinese Community Doctors
关键词 苓甘五味姜辛汤 三子养亲汤 哮喘-慢阻肺重叠综合征 Linggan Wuwei Jiangxin Decoction Sanzi Yangqin Decoction Asthma-chronic obstructive pulmonary disease overlap syndrome
  • 相关文献

参考文献4

二级参考文献84

  • 1张庆祥,于少泓,孙广仁,杨勇,于梅.哮喘病寒饮蕴肺证大鼠病理模型的建立与评价[J].山东中医杂志,2006,25(2):120-122. 被引量:19
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3Kim HY,DeKruyff RH,Umetsu DT.The many paths to asthma:phenotype shaped by innate and adaptive immunity[J].Nat Immunol,2010,11(7):577-584.
  • 4Adeock 1M,Ito K.Steroid resistance in asthma:a major problem requiring novel solutions or a non-issue?[J].Curr Opin Pharmacol,2004,4(3):257-262.
  • 5Barnes PJ.Immunology of asthma and chronic obstructive pulmonary disease[J].Nat Rev Immunol,2008,8(3):183-192.
  • 6Fulkerson PC,Fischetti CA,McBride ML,et al.A central regulatory role for eosinophiis and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation[J].Proc Natl Acad Sci USA,2006,103(44):16418-16423.
  • 7Oehkur SI,Jacobsen EA,Protheroe CA,et al.Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma[J].J lmmunol,2007,178(12):7879-7889.
  • 8Ben S,Li X,Xu F,et al.Treatment with anti-CC chemokine receptor 3 monoclonal antibody or dexamethasone inhibits the migration and differentiation of bone marrow CD34 progenitor cells in an allergic mouse model[J].Allergy,2008,63(9):1164-1176.
  • 9Jacobsen EA,Ochkur SI,Peru RS,et al.Allergic pulmonary inflammation in mice is dependent on eosinophilinduced recruitment of effector T cells[J].J Exp Med,2008,205(3):699-710.
  • 10Perros F,Hoogsteden HC,Coyle AJ,et al.Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation[J].Allergy,2009,64(7):995-1002.

共引文献134

同被引文献134

引证文献10

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部